{
    "code": "02002506",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02002506",
    "time": "2020-02-25 08:11:50",
    "許可證字號": "衛署藥輸字第002506號",
    "註銷狀態": "已註銷",
    "註銷日期": "75\/04\/25",
    "註銷理由": "有效期間已屆未能補件",
    "製造許可登錄編號": "",
    "有效日期": "71\/12\/21",
    "發證日期": "62\/12\/21",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00200250609",
    "中文品名": "德參注射液",
    "英文品名": "DEXAN INJECTION",
    "適應症": "休克、血液疾患之手術準備、衰弱患者之手術準備、副腎上腺摘除手術、風濕關節炎、脊髓炎、血清病、皮膚炎",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "DEXAMETHASONE (SODIUM METASULFOBENZOATE)",
    "限制項目": "02輸　入",
    "申請商名稱": "1216901100  創富國際有限公司",
    "申請商地址": "台北松江路３６６之５號６樓",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0065000  FUJI PHARMACEUTICAL CO., LTD.",
            "製造廠廠址": "1515, TSUJIGADO, MIZUHASHI, TOYAMA-SHI, TOYAMA, JAPAN.1-9-11,SHIKAHAMA ADATI-KU TOKYO, JAPAN",
            "製造廠公司地址": "1-9-11,SHIKAHAMA ADATI-KU TOKYO, JAPAN",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6804009651",
            "成分名稱": "DEXAMETHASONE (SODIUM METASULFOBENZOATE)",
            "含量描述": "(SALT) (5MG) 3.3",
            "含量": "",
            "單位": "MG"
        }
    ]
}